Advertisement
Advertisement
U.S. Markets close in 3 hrs 9 mins
Advertisement
Advertisement
Advertisement
Advertisement

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
21.40-1.84 (-7.92%)
As of 12:49PM EST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts

    Nurix leads protein modulation field with four active clinical stage programs Anticipates data-rich 2022 with clinical-stage programs and a pipeline fueled by proprietary DELigase platform SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today outlined key objectives and anticipated milestones for 2022 and provided an overview of recent progress. “2021 was a significant and highly p

  • TipRanks

    2 “Strong Buy” Stocks Primed for 2022 Gains

    Wall Street traders have no shortage of cliches, and here’s a happy thought for the New Year: ‘So goes January, so goes the year.’ Sam Stovall, chief investment strategist from CFRA Research, has taken note of this quirk, writing: “If the market does well in the month of January, then it usually does well for the full year. But if we find that a lot of money has flowed into the markets, right off the bat, then the indication is that it's likely to be a very good year.” Talking of sentiment, the

  • GlobeNewswire

    Nurix Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

    SAN FRANCISCO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix will present an overview of corporate performance in 2021 and major goals for 2022 at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 5:15 pm ET. The presentation will be webcast live and may be accessed v

Advertisement
Advertisement